User menu

Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.

Bibliographic reference Pirard, Céline ; Loumaye, Ernest ; Laurent , Pascale ; Wyns, Christine. Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.. In: International Journal of Endocrinology, Vol. 2015, p. 727569 [1-10] (2015)
Permanent URL
  1. Journal of reproduction and fertility. Supplement, 55, 101 (2000)
  2. Pritts E.A., Luteal phase support in infertility treatment: a meta-analysis of the randomized trials, 10.1093/humrep/17.9.2287
  3. Smitz J., Camus M., Devroey P., Bollen N., Tournaye H., Van Steirteghem A.C., CLINICAL REPORT, 10.1093/oxfordjournals.humrep.a137324
  4. van der Linden Michelle, Buckingham Karen, Farquhar Cindy, Kremer Jan AM, Metwally Mostafa, Luteal phase support for assisted reproduction cycles, 10.1002/14651858.cd009154.pub2
  5. Fujii S., Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF, 10.1093/humrep/16.8.1671
  6. Tesarik J., Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation, 10.1093/humrep/deh235
  7. Tesarik J., Hazout A., Mendoza-Tesarik R., Mendoza N., Mendoza C., Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles, 10.1093/humrep/del173
  8. Lambalk C. B., Homburg R., GnRH agonist for luteal support in IVF? Setting the balance between enthusiasm and caution, 10.1093/humrep/del321
  9. Qublan H., Amarin Z., Al-Quda M., Diab F., Nawasreh M., Malkawi S., Balawneh M., Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of ≤7 mm on day of egg retrieval, 10.1080/14647270701704768
  10. Razieh Dehghani Firouzabadi, Maryam Ayazi Rozbahani, Nasim Tabibnejad, Beneficial Effect of Luteal-phase Gonadotropin-releasing Hormone Agonist Administration on Implantation Rate Afterintracytoplasmic Sperm Injection, 10.1016/s1028-4559(09)60297-7
  11. Isik A.Z., Caglar G.S., Sozen E., Akarsu C., Tuncay G., Ozbıcer T., Vicdan K., Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study, 10.1016/j.rbmo.2009.04.001
  12. Majumdar Abha, Inamdar DattaprasadB, Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome, 10.4103/0974-1208.106341
  13. Kung Hsiao-Fan, Chen Ming-Jer, Guua Hwa-Fen, Chen Ya-Fang, Yi Yu-Chiao, Yen-Ping Ho Jason, Chou Min-Min, Luteal phase support with decapeptyl improves pregnancy outcomes in intracytoplasmic sperm injection with higher basal follicle-stimulating hormone or lower mature oocytes, 10.1016/j.jcma.2014.07.001
  14. Yıldız Gülşah Aynaoğlu, Şükür Yavuz Emre, Ateş Can, Aytaç Ruşen, The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial, 10.1016/j.ejogrb.2014.08.026
  15. Pirard C., Donnez J., Loumaye E., GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study, 10.1093/humrep/del072
  16. (1991)
  17. Tavaniotou A, Albano C, Smitz J, Devroey P, Impact of ovarian stimulation on corpus luteum function and embryonic implantation, 10.1016/s0165-0378(01)00134-6
  18. Tavaniotou Asimina, Albano Carola, Smitz Johan, Devroey Paul, Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist, 10.1016/s0015-0282(01)03265-4
  19. Beckers Nicole G. M., Macklon Nicholas S., Eijkemans Marinus J., Ludwig Michael, Felberbaum Ricardo E., Diedrich Klaus, Bustion Shelly, Loumaye Ernest, Fauser Bart C. J. M., Nonsupplemented Luteal Phase Characteristics after the Administration of Recombinant Human Chorionic Gonadotropin, Recombinant Luteinizing Hormone, or Gonadotropin-Releasing Hormone (GnRH) Agonist to Induce Final Oocyte Maturation inin VitroFertilization Patients after Ovarian Stimulation with Recombinant Follicle-Stimulating Hormone and GnRH Antagonist Cotreatment, 10.1210/jc.2002-021953
  20. Albano C., Smitz J., Tournaye H., Riethmüller-Winzen H., Van Steirteghem A., Devroey P., Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles, 10.1093/humrep/14.6.1426
  21. Smitz J., Bourgain C., van Waesberghe L., Camus M., Devroey P., Van Steirteghem A.C., A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation, 10.1093/oxfordjournals.humrep.a137871
  22. Humaidan Peter, Ejdrup Bredkjær Helle, Westergaard Lars Grabow, Yding Andersen Claus, 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study, 10.1016/j.fertnstert.2008.12.042
  23. Castillo J.C., Dolz M., Bienvenido E., Abad L., Casañ E.M., Bonilla-Musoles F., Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support, 10.1016/j.rbmo.2009.11.018
  24. Radesic B., Tremellen K., Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates, 10.1093/humrep/der333
  25. Kol S., Humaidan P., Itskovitz-Eldor J., GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study, 10.1093/humrep/der220
  26. Iliodromiti Stamatina, Lan Vuong Thi, Tuong Ho, Tuan Phung, Humaidan Peter, Nelson Scott M, Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study, 10.1186/1757-2215-6-93
  27. Humaidan P., Thomsen L. H., Alsbjerg B., GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients, 10.1093/humrep/det287
  28. Papanikolaou Evangelos G., Verpoest Willem, Fatemi Human, Tarlatzis Basil, Devroey Paul, Tournaye Herman, A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study, 10.1016/j.fertnstert.2010.09.023
  29. Engmann Lawrence, DiLuigi Andrea, Schmidt David, Benadiva Claudio, Maier Donald, Nulsen John, The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study, 10.1016/j.fertnstert.2007.04.006
  30. Shapiro Bruce S., Daneshmand Said T., Garner Forest C., Aguirre Martha, Hudson Cynthia, Comparison of “triggers” using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin, 10.1016/j.fertnstert.2011.03.109
  31. Orvieto Raoul, Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help?, 10.1016/j.rbmo.2012.03.005
  32. Balasch Juan, Martinez Francisca, Jové Inmaculada, Cabré Luis, Coroleu Buenaventura, Barri Pedro N., Vanrell Juan A., Inadvertent gonadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients, 10.1093/oxfordjournals.humrep.a138210
  33. Ata B., Yakin K., Balaban B., Urman B., GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study, 10.1093/humrep/dem421
  34. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 52, 639 (2007)
  35. Ata B., Urman B., Single dose GnRH agonist administration in the luteal phase of assisted reproduction cycles: is the effect dependent on the type of GnRH analogue used for pituitary suppression?, 10.1016/j.rbmo.2009.10.022
  36. Humaidan P., Ejdrup Bredkjær H., Bungum L., Bungum M., Grøndahl M.L., Westergaard L., Yding Andersen C., GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study, 10.1093/humrep/deh765
  37. Kolibianakis E.M., Schultze-Mosgau A., Schroer A., van Steirteghem A., Devroey P., Diedrich K., Griesinger G., A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists, 10.1093/humrep/dei150
  38. Youssef Mohamed AFM, Van der Veen Fulco, Al-Inany Hesham G, Griesinger Georg, Mochtar Monique H, van Wely Madelon, Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles, 10.1002/14651858.cd008046.pub2
  39. Acevedo Belen, Gomez-Palomares Jose Luis, Ricciarelli Elisabetta, Hernández Eleuterio R., Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates, 10.1016/j.fertnstert.2006.05.049
  40. Griesinger Georg, Kolibianakis E.M., Papanikolaou E.G., Diedrich K., Van Steirteghem A., Devroey P., Ejdrup Bredkjaer Helle, Humaidan Peter, Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles, 10.1016/j.fertnstert.2006.12.006
  41. Casan E. M., GnRH mRNA and protein expression in human preimplantation embryos, 10.1093/molehr/5.3.234
  42. Casan E. M., Human Oviductal Gonadotropin-Releasing Hormone: Possible Implications in Fertilization, Early Embryonic Development, and Implantation, 10.1210/jc.85.4.1377
  43. Raga Francisco, Casañ Eva Maria, Kruessel Jan, Wen Yan, Bonilla-Musoles Fernando, Polan Mary Lake, The Role of Gonadotropin-Releasing Hormone in Murine Preimplantation Embryonic Development1, 10.1210/endo.140.8.6899
  44. Kawamura Kazuhiro, Fukuda Jun, Kumagai Jin, Shimizu Yasushi, Kodama Hideya, Nakamura Akira, Tanaka Toshinobu, Gonadotropin-Releasing Hormone I Analog Acts as an Antiapoptotic Factor in Mouse Blastocysts, 10.1210/en.2004-1646
  45. Nam Dong Hyun, Lee So Hyun, Kim Hye Soo, Lee Gab Sang, Jeong Yeon Woo, Kim Sue, Kim Ji Hye, Kang Sung Keun, Lee Byeong Chun, Hwang Woo Suk, The role of gonadotropin-releasing hormone (GnRH) and its receptor in development of porcine preimplantation embryos derived from in vitro fertilization, 10.1016/j.theriogenology.2004.04.004
  46. Journal of Clinical Endocrinology and Metabolism, 80, 580 (1995)
  47. Islami D., Comparison of the effects of GnRH-I and GnRH-II on HCG synthesis and secretion by first trimester trophoblast, 10.1093/molehr/7.1.3
  48. Raga Francisco, Casañ Eva Maria, Kruessel Jan S., Wen Yan, Huang Hong-Yuan, Nezhat Camran, Polan Mary Lake, Quantitative Gonadotropin-Releasing Hormone Gene Expression and Immunohistochemical Localization in Human Endometrium Throughout the Menstrual Cycle1, 10.1095/biolreprod59.3.661
  49. Shemesh M, Actions of gonadotrophins on the uterus, 10.1530/rep.0.1210835
  50. Klemmt P. A.B., Liu F., Carver J. G., Jones C., Brosi D., Adamson J., Mardon H. J., McVeigh E., Effects of gonadotrophin releasing hormone analogues on human endometrial stromal cells and embryo invasion in vitro, 10.1093/humrep/dep181
  51. Oliveira João, Baruffi Ricardo, Petersen Cláudia G, Mauri Ana L, Cavagna Mario, Franco José G, Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis, 10.1186/1477-7827-8-107
  52. Stewart E, Gonadotropins and the uterus: is there a gonad-independent pathway?, 10.1016/s1071-5576(01)00136-8
  53. Rao C.V, Lei Z.M, Consequences of targeted inactivation of LH receptors, 10.1016/s0303-7207(01)00694-3
  54. Tesarik Jan, Hazout André, Mendoza Carmen, Luteinizing hormone affects uterine receptivity independently of ovarian function, 10.1016/s1472-6483(10)61729-4
  55. Loumaye Ernest, Depreester Suzy, Donnez Jacques, Thomas Karl, Immunoreactive relaxin surge in the peritoneal fluid of women during the midluteal phase**Supported by grant 3 4450 83 from the Fonds de la Recherche Scientifique Medicale Belgium., 10.1016/s0015-0282(16)48256-7
  56. Licht P., Russu V., Wildt L., On the Role of Human Chorionic Gonadotropin (hCG) in the Embryo-Endometrial Microenvironment: Implications for Differentiation and Implantation, 10.1055/s-2001-13909
  57. Human Reproduction, 21 (2006)